The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Expression of lymphocyte activation gene 3 (LAG-3) on B cells is induced by T cells
Abstract
Lymphocyte activation gene 3 (LAG-3/CD223) is a CD4 homolog known to be selectively expressed in activated T and NK cells. It is thought to have a negative regulatory function in T cells. With the help of new monoclonal antibodies against mouse LAG-3, we show that LAG-3 surface expression is not limited to activated T and NK cells but is also found on activated B cells. Induction of B cell surface expression is T cell dependent and mediated by a soluble factor. The majority of LAG-3 on B cell surface is endogenously produced, even though soluble LAG-3 is present in the culture supernatants and can be passively absorbed. As B cells express LAG-3 in a T cell dependent manner and not when activated by Toll-like-receptor agonists alone, we propose LAG-3 as a new marker of T cell induced B cell activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of LAG-3 in Regulatory T Cells
Huang, C.-T., Workman, C. J., Flies, D., Pan, X., Marson, A. L., Zhou, G., Hipkiss, E. L., Ravi, S., Kowalski, J., Levitsky, H. I., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.010 · Cited by 1,325
LAG-3, a novel lymphocyte activation gene closely related to CD4.
Triebel, F., Jitsukawa, S., Baixeras, E., Roman-Roman, S., Genevee, C., Viegas-Pequignot, E., & Hercend, T. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.5.1393 · Cited by 925
Baixeras, E., Huard, B., Miossec, C., Jitsukawa, S., Martin, M., Hercend, T., Auffray, C., Triebel, F., & Piatier-Tonneau, D. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.2.327 · Cited by 397
Huard, B., Prigent, P., Tournier, M., Bruniquel, D., & Triebel, F. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250949 · Cited by 391
Cutting Edge: Molecular Analysis of the Negative Regulatory Function of Lymphocyte Activation Gene-3
Workman, C. J., Dugger, K. J., & Vignali, D. A. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5392 · Cited by 389
Workman, C. J., Cauley, L. S., Kim, I.-J., Blackman, M. A., Woodland, D. L., & Vignali, D. A. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5450 · Cited by 351
The CD4‐related molecule, LAG‐3 (CD223), regulates the expansion of activated T cells
Workman, C. J., & Vignali, D. A. A. (2003) · European Journal of Immunology · doi:10.1002/eji.200323382 · Cited by 319
Divergent Therapeutic and Immunologic Effects of Oligodeoxynucleotides with Distinct CpG Motifs
Ballas, Z. K., Krieg, A. M., Warren, T., Rasmussen, W., Davis, H. L., Waldschmidt, M., & Weiner, G. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.4878 · Cited by 252
CD3/TCR complex‐associated lymphocyte activation gene‐3 molecules inhibit CD3/TCR signaling
Hannier, S., Tournier, M., Bismuth, G., & Triebel, F. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.4058 · Cited by 248
Huard, B., Tournier, M., Hercend, T., Triebel, F., & Faure, F. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241246 · Cited by 241
Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo
Lienhardt, C., Azzurri, A., Amedei, A., Fielding, K., Sillah, J., Sow, O. Y., Bah, B., Benagiano, M., Diallo, A., Manetti, R., et al. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200206)32:6<1605::aid-immu1605>3.0.co;2-6 · Cited by 227
Huard, B., Gaulard, P., Faure, F., Hercend, T., & Triebel, F. (1994) · Immunogenetics · doi:10.1007/bf00241263 · Cited by 202
Maturation and Activation of Dendritic Cells Induced by Lymphocyte Activation Gene-3 (CD223)
Andreae, S., Piras, F., Burdin, N., & Triebel, F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.8.3874 · Cited by 187
Independent Modes of Natural Killing Distinguished in Mice Lacking Lag3
Miyazaki, T., Dierich, A., Benoist, C., & Mathis, D. (1996) · Science · doi:10.1126/science.272.5260.405 · Cited by 179
LAG-3: a regulator of T-cell and DC responses and its use in therapeutic vaccination
Triebel, F. (2003) · Trends in Immunology · doi:10.1016/j.it.2003.10.001 · Cited by 150
Andreae, S., Buisson, S., & Triebel, F. (2003) · Blood · doi:10.1182/blood-2003-01-0273 · Cited by 150
Biochemical Analysis of the Regulatory T Cell Protein Lymphocyte Activation Gene-3 (LAG-3; CD223)
Li, N., Workman, C. J., Martin, S., & Vignali, D. A. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6806 · Cited by 138
Huard, B., Prigent, P., Pagès, F., Bruniquel, D., & Triebel, F. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260533 · Cited by 132
Avice, M.-N., Sarfati, M., Triebel, F., Delespesse, G., & Demeure, C. E. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.5.2748 · Cited by 130
Avice, M.-N., Sarfati, M., Triebel, F., et al. (1999) · PubMed · Cited by 114
Acquisition of CD80 (B7-1) by T Cells
Sabzevari, H., Kantor, J. A., Jaigirdar, A. A., Tagaya, Y., Naramura, M., Hodge, J. W., Bernon, J., & Schlom, J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2505 · Cited by 108
Demeure, C. E., Wolfers, J., Martin‐Garcia, N., Gaulard, P., & Triebel, F. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00184-8 · Cited by 104
Lymphocyte activation gene-3 induces tumor regression and antitumor immune responses
Prigent, P., mir, S. E., Dréano, M., & Triebel, F. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199912)29:12<3867::aid-immu3867>3.0.co;2-e · Cited by 97
LAG-3 does not define a specific mode of natural killing in human
Huard, B., Tournier, M., & Triebel, F. (1998) · Immunology Letters · doi:10.1016/s0165-2478(97)00170-3 · Cited by 95
Cappello, P., Triebel, F., Iezzi, M., Caorsi, C., Quaglino, E., Lollini, P., Amici, A. R. D., Carlo, E. D., Musiani, P., Giovarelli, M., et al. (2003) · PubMed · Cited by 89
Cloning of Murine LAG-3 by Magnetic Bead Bound Homologous Probes and PCR (GENE-CAPTURE PCR)
Mastrangeli, R., Micangeli, E., & Donini, S. (1996) · Analytical Biochemistry · doi:10.1006/abio.1996.0382 · Cited by 42
Soluble mouse major histocompatibility complex class II molecules produced in Drosophila cells
Wallny, H., Sollami, G., & Karjalainen, K. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250520 · Cited by 33
Self-citationPhenotypic analysis of the murine CD4-related glycoprotein, CD223 (LAG-3)
(2002) · doi:10.1002/1521-4141(200208)32:8<2255::aid-immu2255>3.0.co;2-a
Cited by
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Topalian, S. L., Drake, C. G., & Pardoll, D. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.001 · Cited by 4,229
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
Qin, S., Xu, L., Yi, M., Yu, S., Wu, K., & Luo, S. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1091-2 · Cited by 1,145
LAG 3 (CD 223) as a cancer immunotherapy target
Andrews, L. P., Marciscano, A. E., Drake, C. G., & Vignali, D. A. A. (2017) · Immunological Reviews · doi:10.1111/imr.12519 · Cited by 956
Clinical blockade of PD1 and LAG3 — potential mechanisms of action
Nguyen, L. T., & Ohashi, P. S. (2015) · Nature Reviews Immunology · doi:10.1038/nri3790 · Cited by 627
Grosso, J. F., Kelleher, C. C., Harris, T. J., Maris, C. H., Hipkiss, E. L., De Marzo, A., Anders, R., Netto, G., Getnet, D., Bruno, T. C., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31184 · Cited by 547
Metadata
- Authors
- Kisielow, M., Kisielow, J., Capoferri-Sollami, G., & Karjalainen, K.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2005-07
- Volume
- 35
- Issue
- 7
- Pages
- 2081-2088
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2091794422
- Cited by
- 271
- References
- 28
- FWCI
- 0.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.